Compound details
Ixerochinoside
| Compound ID | CDAMM02277 |
|---|---|
| Common name | Ixerochinoside | IUPAC name | [3,4,5-trihydroxy-6-[[4-[2-(4-hydroxyphenyl)acetyl]oxy-3,6,9-trimethylidene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-8-yl]oxy]oxan-2-yl]methyl 2-(4-hydroxyphenyl)acetate |
| Molecular formula | C37H40O13 |
| Retention time | 0.41 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 693.253 | Theoretical mz | 693.254 |
| Error | 1.26 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4483 |
| Inchi key | HMUFZGUGGDDWBV-WGNCPBMBNA-N |
|---|---|
| Smiles | O=C1OC2C(C1=C)C(OC(=O)CC3=CC=C(O)C=C3)CC(=C)C4CC(OC5OC(COC(=O)CC6=CC=C(O)C=C6)C(O)C(O)C5O)C(=C)C24 |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |